MSANTD2
Myb/SANT-like DNA-binding domain-containing protein 2
Also known as: C11orf61, FLJ23342, MSD2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6P1R3
- Gene
- MSANTD2
- Ensembl
- ENSG00000120458
- Chromosome
- 11
- Canonical length
- 559 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
No narrative summary is available for MSANTD2 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
559 residues, UniProt reviewed canonical sequence.
>Q6P1R3|MSANTD2
1 MAAPCGSELP ANSPLKIPKM EVLSPASPGG LSDGNPSLSD PSTPRGASPL GPGSAAGSGA
61 AASGGLGLGL GGRSAASSSV SFSPGGGGGG AAAAAAAACR GMSWTPAETN ALIAVWGNER
121 LVEARYQQLE GAGTVFGSKA PGPAMYERVS RALAELGYER TPSQCRERIK TLRRCYSRVK
181 EHGVGKRKSS YTFEQLEQVF GQGGWDAQPC QPVLINSSGL YQELESDGST MEDYSQEDWG
241 NHSQDLHGYP TDQELDEIPV TKRTLKIKQE SSEEAQKRDI MQNIVQILES VQLKWELFQS
301 WTDFSRLHLS NKLAIFGIGY NTRWKEDIRY HYAEISSQVP LGKRLREYFN SEKPEGRIIM
361 TRVQKMNWKN VYYKFLEITI SEARCLELHM EIDWIPIAHS KPTGGNVVQY LLPGGIPKSP
421 GLYAIGYEEC IERPLSPHME QSSLDPGKEG RVDLETLSAQ ASLQVEIEPT RIIYCYLGIA
481 EVRTLQQCLF LHFQANTKTF SKDWVGINGF LSQNCIVDPG VSPKSIYIKF VEVERDFLSA
541 GSLVECLEKA IGYPLKFNNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MSANTD2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 22 nTPM
- kidney: 14 nTPM
- pituitary gland: 13 nTPM
- cervix: 12 nTPM
- pancreas: 12 nTPM
- ovary: 11 nTPM
Single-cell type
- loop of henle epithelial cells: 83 nCPM
- lactotrophs: 82 nCPM
- choroid plexus epithelial cells: 76 nCPM
- somatotrophs: 70 nCPM
- distal convoluted tubule cells: 70 nCPM
- microglia: 65 nCPM
Immune cell
- T-reg: 1.1 nTPM
- memory CD8 T-cell: 0.9 nTPM
- naive B-cell: 0.8 nTPM
- eosinophil: 0.6 nTPM
- gdT-cell: 0.6 nTPM
- memory CD4 T-cell: 0.5 nTPM
Brain region
- white matter: 15 nTPM
- basal ganglia: 11 nTPM
- pons: 11 nTPM
- midbrain: 11 nTPM
- choroid plexus: 11 nTPM
- hypothalamus: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.9
- gnomAD missense Z
- 2.3
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- Myb/SANT-like DNA-binding domain 4
- Myb/SANT-like DNA-binding domain
- Myb/SANT-like DNA-binding domain-containing protein 2
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MSANTD2 as an antibody target. Whether an autoantibody or antibody against MSANTD2 could matter depends on whether native MSANTD2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MSANTD2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MSANTD2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...